Lapad, John P.
HRN: 18-60-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2023
CEFUROXIME 750MG (VIAL)
10/24/2023
10/30/2023
IV
425mg
Q8h
Acute Gastroenteritis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes